Journal of cosmetic dermatology · 2018
Evidence-based treatment for gynoid lipodystrophy: A review of the recent literature.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pérez Atamoros Francisco M, Alcalá Pérez Daniel, Asz Sigall Daniel, Ávila Romay Alfonsina A, Barba Gastelum José A, de la Peña Salcedo José A, Escalante Salgado Pablo E, Gallardo Palacios Guillermo J, Guerrero-Gonzalez Guillermo A, Morales De la Cerda Rodrigo, Ponce Olivera Rosa María, Rossano Soriano Fabiola, Solís Tinoco Eduardo, Welsh Hernández Esperanza C
Аннотация
Gynoid lipodystrophy (GLD) is a structural, inflammatory, and biochemical disorder of the subcutaneous tissue causing alterations in the topography of the skin. Commonly known as "cellulite," GLD affects up to 90% of women, practically in all stages of the life cycle, beginning in puberty. It is a clinical condition that considerably affects the patients' quality of life. It is a frequent reason for consultation, although the patients resort to empirical, improvised, nonevidence-based treatments which discourage and can be a source of frustration not only because of the lack of results but also due to the complications derived from those treatments. In this article, a panel of experts from different specialties involved in the management of this clinical skin disorder presents the results of a systematic literature search and of the consensus discussion of the evidence obtained from different treatments currently available. The analysis was divided into topical, systemic, noninvasive, and minimally invasive treatments.